• FirefoxTry Yahoo Finance on Firefox »
  •  Dow down 0.11% Nasdaq up 0.09%
    {"s" : "^dji,^ixic","k" : "p20","o" : "","j" : ""}
     Dow down 0.11% Nasdaq up 0.09%
    {"s" : "^dji,^ixic","k" : "p20","o" : "","j" : ""}

    Quote Results

    Add Quotes

    SymbolTime & PriceChg & % ChgDay's Low & HighVolumeAvg VolMkt CapChartMore Info
    Dec 2 25.89 +0.080 +0.31% 25.86 26.11 8,836,805 6,219,390 67.39B Sparkline Chart Chart, News, Stats, Options, Board
    {"s" : "azn","k" : "t53,l84,c63,p43,g53,h53,v53,j10,c63,l84,p43,a00,a50,b00,b60,g00,h00,t53,v53","o" : "","j" : "c63,l84,p43,t53,v53"}

    Quotes delayed, except where indicated otherwise.

    Recent News

    day and time symbols news headline and source
    Friday December 2, 2016
    Pharma Stock Roundup: Nivalis Falls on Study Data, Priority Reviews for Merck's Keytruda Zacks06:40am EST
    Thursday December 1, 2016
    Is Celgene Corporation (CELG) Worthy of Your Portfolio? at Insider Monkey09:30am EST
    AstraZeneca in broad drug deal with Bicycle worth up to $1 bln Reuters07:42am EST
    Wednesday November 30, 2016
    3 Horrible Stocks for Retirees at Motley Fool11:02am EST
    Monday November 28, 2016
    Pharma Stock Roundup: Lilly Alzheimer's Drug Fails, J&J in Acquisition Talks with ALIOF Zacks08:49am EST
    Friday November 25, 2016
    AstraZeneca upgraded by Liberum Briefing.com08:49am EST
    Thursday November 24, 2016
    Should You Light Up An Investment In Reynolds American, Inc. (RAI)? at Insider Monkey01:54pm EST
    GSK chases Astra with start of big anaemia drug trials Reuters07:13am EST
    Wednesday November 23, 2016
    AstraZeneca: Nexium Pay-For-Delay Win Upheld (AZN) at Investopedia04:57pm EST
    AstraZeneca PLC (ADR) (AZN), Ranbaxy Laboratories Limited (ADR) (RBXLY) Wins Over Illegal Deal Case at Insider Monkey11:05am EST
    AstraZeneca: FDA Lifts Hold on Head & Neck Cancer Trials Zacks05:42am EST
    Tuesday November 22, 2016
    AstraZeneca, Novartis Drop into Tuesday’s 52-Week Low Club 24/7 Wall St.04:04pm EST
    Is This Drug Inovio Pharmaceuticals' Best Chance for Success? at Motley Fool03:42pm EST
    [$$] AstraZeneca given green light to resume cancer drug trials at Financial Times01:12pm EST
    AstraZeneca cleared to resume enrolment in cancer drug trials Reuters03:56am EST
    U.S. FDA lifts hold on AstraZeneca head and neck cancer trials Reuters02:28am EST
    Monday November 21, 2016
    Brace Yourself: AstraZeneca Could Be a Fourth Entrant into the PD-1/PD-L1 Drug Class at Market Realist10:04am EST
    $13 Billion Opportunity: 5 Companies That Could Dominate the Alzheimer's Disease Market at Motley Fool08:46am EST
    Friday November 18, 2016
    Bristol Myers Squibb Co. (BMY), Alkermes Plc (ALKS) & More: How Opus Point’s Bet on Healthcare Sector Paid Off? at Insider Monkey04:49pm EST
    Wednesday November 16, 2016
    ETFs with exposure to AstraZeneca Plc : November 16, 2016 at Capital Cube12:43pm EST
    Tuesday November 15, 2016
    These Drugs Led Medicare Spending (GILD, SNY) at Investopedia01:55pm EST
    AstraZeneca’s Other Products in 3Q16 at Market Realist10:04am EST